{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:27:21Z","timestamp":1707352041245},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00115-024-01622-8","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T07:02:07Z","timestamp":1706252527000},"page":"169-178","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Migr\u00e4ne und mitochondriale Erkrankungen","Migraine and mitochondrial diseases"],"prefix":"10.1007","volume":"95","author":[{"given":"Lucia","family":"H\u00e4mmerl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Kraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,26]]},"reference":[{"key":"1622_CR1","volume-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"C Kornblum","year":"2021","unstructured":"Kornblum\u00a0C et al (2021) Mitochondriale Erkrankungen, S1-Leitlinie. In: Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie"},{"key":"1622_CR2","volume-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"H-C Diener","year":"2022","unstructured":"Diener\u00a0H\u2011C, F\u00f6rderreuther\u00a0S, Kropp\u00a0P (2022) Therapie der Migr\u00e4neattacke und Prophylaxe der Migr\u00e4ne, S1-Leitlinie, 2022, DGN und DMKG. In: Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie"},{"key":"1622_CR3","doi-asserted-by":"publisher","first-page":"225-IN6","DOI":"10.1016\/0022-5193(67)90079-3","volume":"14","author":"L Sagan","year":"1967","unstructured":"Sagan\u00a0L (1967) On the origin of mitosing cells. J\u00a0Theor Biol 14:225-IN6. https:\/\/doi.org\/10.1016\/0022-5193(67)90079-3","journal-title":"J Theor Biol"},{"key":"1622_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.spen.2013.09.002","volume":"20","author":"WR Yorns","year":"2013","unstructured":"Yorns\u00a0WR, Hardison\u00a0HH (2013) Mitochondrial dysfunction in migraine. Semin Pediatr Neurol 20:188\u2013193. https:\/\/doi.org\/10.1016\/j.spen.2013.09.002","journal-title":"Semin Pediatr Neurol"},{"key":"1622_CR5","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2021.0251","author":"T Klopstock","year":"2021","unstructured":"Klopstock\u00a0T, Priglinger\u00a0C, Yilmaz\u00a0A, Kornblum\u00a0C, Distelmaier\u00a0F, Prokisch\u00a0H (2021) Mitochondrial disorders. Dtsch \u00c4rztebl Int. https:\/\/doi.org\/10.3238\/arztebl.m2021.0251","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"1622_CR6","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/mgg3.500","volume":"6","author":"A Abicht","year":"2018","unstructured":"Abicht\u00a0A, Scharf\u00a0F, Kleinle\u00a0S, Sch\u00f6n\u00a0U, Holinski-Feder\u00a0E, Horvath\u00a0R et al (2018) Mitochondrial and nuclear disease panel (Mito-aND-Panel): Combined sequencing of mitochondrial and nuclear DNA by a\u00a0cost-effective and sensitive NGS-based method. Mol Genet Genomic Med 6:1188\u20131198. https:\/\/doi.org\/10.1002\/mgg3.500","journal-title":"Mol Genet Genomic Med"},{"key":"1622_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-54671-6_76-2","volume-title":"Mitochondriopathien","author":"W Sperl","year":"2019","unstructured":"Sperl\u00a0W, Freisinger\u00a0P (2019) Mitochondriopathien, S\u00a01\u201315 https:\/\/doi.org\/10.1007\/978-3-642-54671-6_76-2"},{"key":"1622_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1055\/a-1514-2141","volume":"05","author":"C Stendel","year":"2022","unstructured":"Stendel\u00a0C, Neuhofer\u00a0CM, Klopstock\u00a0T (2022) Mitochondriale Erkrankungen \u2013 Ein Update zu Klinik, Diagnostik und Therapie. Neurol Up2date 05:73\u201396. https:\/\/doi.org\/10.1055\/a-1514-2141","journal-title":"Neurol Up2date"},{"key":"1622_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41576-018-0022-1","volume":"19","author":"FL Raymond","year":"2018","unstructured":"Raymond\u00a0FL, Horvath\u00a0R, Chinnery\u00a0PF (2018) First-line genomic diagnosis of mitochondrial disorders. Nat Rev Genet 19:399\u2013400. https:\/\/doi.org\/10.1038\/s41576-018-0022-1","journal-title":"Nat Rev Genet"},{"key":"1622_CR10","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/brain\/awr170","volume":"134","author":"T Klopstock","year":"2011","unstructured":"Klopstock\u00a0T, Yu-Wai-Man\u00a0P, Dimitriadis\u00a0K, Rouleau\u00a0J, Heck\u00a0S, Bailie\u00a0M et al (2011) A\u00a0randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy. Brain 134:2677\u20132686. https:\/\/doi.org\/10.1093\/brain\/awr170","journal-title":"Brain"},{"key":"1622_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.mito.2020.05.004","volume":"53","author":"LH Tiehuis","year":"2020","unstructured":"Tiehuis\u00a0LH, Koene\u00a0S, Saris\u00a0CGJ, Janssen\u00a0MCH (2020) Mitochondrial migraine; a\u00a0prevalence, impact and treatment efficacy cohort study. Mitochondrion 53:128\u2013132. https:\/\/doi.org\/10.1016\/j.mito.2020.05.004","journal-title":"Mitochondrion"},{"key":"1622_CR12","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"SL James","year":"2018","unstructured":"James\u00a0SL, Abate\u00a0D, Abate\u00a0KH, Abay\u00a0SM, Abbafati\u00a0C, Abbasi\u00a0N et\u00a0al (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a\u00a0systematic analysis for the Global Burden of Disease Study 2017. Lancet 392:1789\u20131858. https:\/\/doi.org\/10.1016\/S0140-6736(18)32279-7","journal-title":"Lancet"},{"key":"1622_CR13","doi-asserted-by":"publisher","DOI":"10.25646\/6988.2","author":"M Porst","year":"2020","unstructured":"Porst\u00a0M, Wengler\u00a0A, Leddin\u00a0J, Neuhauser\u00a0H, Katsarava\u00a0Z, von der Lippe\u00a0E et al (2020) Migr\u00e4ne und Spannungskopfschmerz in Deutschland. Pr\u00e4valenz und Erkrankungsschwere im Rahmen der Krankheitslast-Studie BURDEN 2020. J\u00a0Health Monit. https:\/\/doi.org\/10.25646\/6988.2","journal-title":"J Health Monit"},{"key":"1622_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1212\/WNL.38.5.751","volume":"38","author":"P Montagna","year":"1988","unstructured":"Montagna\u00a0P, Gallassi\u00a0R, Medori\u00a0R, Govoni\u00a0E, Zeviani\u00a0M, Mauro\u00a0SD et\u00a0al (1988) MELAS syndrome: Characteristic migrainous and epileptic features and maternal transmission. Neurology 38:751\u2013751. https:\/\/doi.org\/10.1212\/WNL.38.5.751","journal-title":"Neurology"},{"key":"1622_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1468-2982.2005.01059.x","volume":"26","author":"M Sparaco","year":"2006","unstructured":"Sparaco\u00a0M, Feleppa\u00a0M, Lipton\u00a0RB, Rapoport\u00a0AM, Bigal\u00a0ME (2006) Mitochondrial dysfunction and migraine: Evidence and hypotheses. Cephalalgia 26:361\u2013372. https:\/\/doi.org\/10.1111\/j.1468-2982.2005.01059.x","journal-title":"Cephalalgia"},{"key":"1622_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/head.13219","volume":"58","author":"T Kraya","year":"2018","unstructured":"Kraya\u00a0T, Deschauer\u00a0M, Joshi\u00a0PR, Zierz\u00a0S, Gaul\u00a0C (2018) Prevalence of headache in patients with mitochondrial disease: a\u00a0cross-sectional study. Headache 58:45\u201352. https:\/\/doi.org\/10.1111\/head.13219","journal-title":"Headache"},{"key":"1622_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/ene.12832","volume":"23","author":"S Guo","year":"2016","unstructured":"Guo\u00a0S, Esserlind\u00a0AL, Andersson\u00a0Z, Frederiksen\u00a0AL, Olesen\u00a0J, Vissing\u00a0J et\u00a0al (2016) Prevalence of migraine in persons with the 3243A\u3009G mutation in mitochondrial DNA. Eur J Neurol 23:175\u2013181. https:\/\/doi.org\/10.1111\/ene.12832","journal-title":"Eur J Neurol"},{"key":"1622_CR18","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1177\/0333102417723568","volume":"38","author":"C Vollono","year":"2018","unstructured":"Vollono\u00a0C, Primiano\u00a0G, Della Marca\u00a0G, Losurdo\u00a0A, Servidei\u00a0S (2018) Migraine in mitochondrial disorders: Prevalence and characteristics. Cephalalgia 38:1093\u20131106. https:\/\/doi.org\/10.1177\/0333102417723568","journal-title":"Cephalalgia"},{"key":"1622_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08206-z","author":"A Terrin","year":"2022","unstructured":"Terrin\u00a0A, Bello\u00a0L, Valentino\u00a0ML, Caporali\u00a0L, Sorar\u00f9\u00a0G, Carelli\u00a0V et\u00a0al (2022) The relevance of migraine in the clinical spectrum of mitochondrial disorders. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-08206-z","journal-title":"Sci Rep"},{"key":"1622_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1001\/archneur.1973.00490260039007","volume":"29","author":"E Skinhoj","year":"1973","unstructured":"Skinhoj\u00a0E (1973) Hemodynamic studies within the brain during migraine. Arch Neurol 29:95\u201398. https:\/\/doi.org\/10.1001\/archneur.1973.00490260039007","journal-title":"Arch Neurol"},{"key":"1622_CR21","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1994.1401021.x","volume-title":"Abnormal platelet mitochondrial function in patients affected by migraine with and without aura","author":"S Sangiorgi","year":"1994","unstructured":"Sangiorgi\u00a0S, Mochi\u00a0M, Riva\u00a0R, Cortelli\u00a0P, Monari\u00a0L, Pierangeli\u00a0G et\u00a0al (1994) Abnormal platelet mitochondrial function in patients affected by migraine with and without aura"},{"key":"1622_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1046\/j.1526-4610.2001.041007629.x","volume":"41","author":"KMA Welch","year":"2001","unstructured":"Welch\u00a0KMA, Nagesh\u00a0V, Aurora\u00a0SK, Gelman\u00a0N (2001) Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41:629\u2013637. https:\/\/doi.org\/10.1046\/j.1526-4610.2001.041007629.x","journal-title":"Headache"},{"key":"1622_CR23","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1177\/0333102412452048","volume":"32","author":"H Reyngoudt","year":"2012","unstructured":"Reyngoudt\u00a0H, Achten\u00a0E, Paemeleire\u00a0K (2012) Magnetic resonance spectroscopy in migraine: What have we learned so far? Cephalalgia 32:845\u2013859. https:\/\/doi.org\/10.1177\/0333102412452048","journal-title":"Cephalalgia"},{"key":"1622_CR24","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/archneur.1993.00540110075008","volume":"50","author":"S DiMauro","year":"1993","unstructured":"DiMauro\u00a0S, Moraes\u00a0CT (1993) Mitochondrial encephalomyopathies. Arch Neurol 50:1197\u20131208. https:\/\/doi.org\/10.1001\/archneur.1993.00540110075008","journal-title":"Arch Neurol"},{"key":"1622_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0022-510X(91)90308-T","volume":"104","author":"N Bresolin","year":"1991","unstructured":"Bresolin\u00a0N, Martinelli\u00a0P, Barbiroli\u00a0B, Zaniol\u00a0P, Ausenda\u00a0C, Montagna\u00a0P et al (1991) Muscle mitochondrial DNA deletion and 31P-NMR spectroscopy alterations in a\u00a0migraine patient. J\u00a0Neurol Sci 104:182\u2013189. https:\/\/doi.org\/10.1016\/0022-510X(91)90308-T","journal-title":"J Neurol Sci"},{"key":"1622_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/0022-510X(94)00283-T","volume":"129","author":"A Uncini","year":"1995","unstructured":"Uncini\u00a0A, Lodi\u00a0R, Di Muzio\u00a0A, Silvestri\u00a0G, Servidei\u00a0S, Lugaresi\u00a0A et al (1995) Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine. J\u00a0Neurol Sci 129:214\u2013222. https:\/\/doi.org\/10.1016\/0022-510X(94)00283-T","journal-title":"J Neurol Sci"},{"key":"1622_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s10194-023-01563-8","volume":"24","author":"J He","year":"2023","unstructured":"He\u00a0J, Zhou\u00a0M, Zhao\u00a0F, Cheng\u00a0H, Huang\u00a0H, Xu\u00a0X et al (2023) FGF-21 and GDF-15 are increased in migraine and associated with the severity of migraine-related disability. J\u00a0Headache Pain 24:28. https:\/\/doi.org\/10.1186\/s10194-023-01563-8","journal-title":"J Headache Pain"},{"key":"1622_CR28","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.2174\/0929867325666180111094336","volume":"25","author":"LM Scholle","year":"2018","unstructured":"Scholle\u00a0LM, Lehmann\u00a0D, Deschauer\u00a0M, Kraya\u00a0T, Zierz\u00a0S (2018) FGF-21 as a\u00a0potential biomarker for mitochondrial diseases. Curr Med Chem 25:2070\u20132081. https:\/\/doi.org\/10.2174\/0929867325666180111094336","journal-title":"Curr Med Chem"},{"key":"1622_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092471","author":"P Burow","year":"2021","unstructured":"Burow\u00a0P, Haselier\u00a0M, Naegel\u00a0S, Scholle\u00a0LM, Gaul\u00a0C, Kraya\u00a0T (2021) The mitochondrial biomarkers fgf-21 and gdf-15 in patients with episodic and chronic migraine. Cells. https:\/\/doi.org\/10.3390\/cells10092471","journal-title":"Cells"},{"key":"1622_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s10194-015-0516-6","volume":"16","author":"C Gaul","year":"2015","unstructured":"Gaul\u00a0C, Diener\u00a0H\u2011C, Danesch\u00a0U (2015) Improvement of migraine symptoms with a\u00a0proprietary supplement containing riboflavin, magnesium and Q10: a\u00a0randomized, placebo-controlled, double-blind, multicenter trial. J\u00a0Headache Pain 16:32. https:\/\/doi.org\/10.1186\/s10194-015-0516-6","journal-title":"J Headache Pain"},{"key":"1622_CR31","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1212\/WNL.42.6.1203","volume":"42","author":"D Bendahan","year":"1992","unstructured":"Bendahan\u00a0D, Desnuelle\u00a0C, Vanuxem\u00a0D, Confort-Gouny\u00a0S, Figarella-Branger\u00a0D, Pellissier\u00a0JF et al (1992) 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology 42:1203\u20131203. https:\/\/doi.org\/10.1212\/WNL.42.6.1203","journal-title":"Neurology"},{"key":"1622_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1212\/WNL.36.1.45","volume":"36","author":"S Ogasahara","year":"1986","unstructured":"Ogasahara\u00a0S, Nishikawa\u00a0Y, Yorifuji\u00a0S, Soga\u00a0F, Nakamura\u00a0Y, Takahashi\u00a0M et al (1986) Treatment of Kearns-Sayre syndrome with coenzyme Q10. Neurology 36:45\u201345. https:\/\/doi.org\/10.1212\/WNL.36.1.45","journal-title":"Neurology"},{"key":"1622_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.nmd.2009.10.014","volume":"20","author":"S Sacconi","year":"2010","unstructured":"Sacconi\u00a0S, Trevisson\u00a0E, Salviati\u00a0L, Aym\u00e9\u00a0S, Rigal\u00a0O, Garcia Redondo\u00a0A et\u00a0al (2010) Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy. Neuromuscul Disord 20:44\u201348. https:\/\/doi.org\/10.1016\/j.nmd.2009.10.014","journal-title":"Neuromuscul Disord"},{"key":"1622_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2020.10.002","volume":"131","author":"M Almannai","year":"2020","unstructured":"Almannai\u00a0M, El-Hattab\u00a0AW, Ali\u00a0M, Soler-Alfonso\u00a0C, Scaglia\u00a0F (2020) Clinical trials in mitochondrial disorders, an update. Mol Genet Metab 131:1\u201313. https:\/\/doi.org\/10.1016\/j.ymgme.2020.10.002","journal-title":"Mol Genet Metab"},{"key":"1622_CR35","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41582-019-0255-4","volume":"15","author":"EC Gross","year":"2019","unstructured":"Gross\u00a0EC, Lisicki\u00a0M, Fischer\u00a0D, S\u00e1ndor\u00a0PS, Schoenen\u00a0J (2019) The metabolic face of migraine\u2014from pathophysiology to treatment. Nat Rev Neurol 15:627\u2013643. https:\/\/doi.org\/10.1038\/s41582-019-0255-4","journal-title":"Nat Rev Neurol"},{"key":"1622_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/14737175.2020.1729130","volume":"20","author":"M Lisicki","year":"2020","unstructured":"Lisicki\u00a0M, Schoenen\u00a0J (2020) Metabolic treatments of migraine. Expert Rev Neurother 20:295\u2013302. https:\/\/doi.org\/10.1080\/14737175.2020.1729130","journal-title":"Expert Rev Neurother"},{"key":"1622_CR37","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/head.14101","volume":"61","author":"S Naegel","year":"2021","unstructured":"Naegel\u00a0S, Burow\u00a0P, Holle\u00a0D, Stoevesandt\u00a0D, Heintz\u00a0S, Thaele\u00a0A et al (2021) Erenumab for migraine prevention in a\u00a0patient with mitochondrial encephalopathy, lactate acidosis, and stroke-like episodes syndrome: A\u00a0case report. Headache 61:694\u2013696. https:\/\/doi.org\/10.1111\/head.14101","journal-title":"Headache"},{"key":"1622_CR38","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1007\/s10072-022-06391-3","volume":"43","author":"G Primiano","year":"2022","unstructured":"Primiano\u00a0G, Rollo\u00a0E, Romozzi\u00a0M, Calabresi\u00a0P, Servidei\u00a0S, Vollono\u00a0C (2022) Preventive migraine treatment in mitochondrial diseases: a\u00a0case report of erenumab efficacy and literature review. Neurol Sci 43:6955\u20136959. https:\/\/doi.org\/10.1007\/s10072-022-06391-3","journal-title":"Neurol Sci"},{"key":"1622_CR39","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1212\/01.WNL.0000078931.87815.B3","volume":"61","author":"T Iizuka","year":"2003","unstructured":"Iizuka\u00a0T, Sakai\u00a0F, Endo\u00a0M, Suzuki\u00a0N (2003) Response to sumatriptan in headache of MELAS syndrome. Neurology 61:577\u2013578. https:\/\/doi.org\/10.1212\/01.WNL.0000078931.87815.B3","journal-title":"Neurology"},{"key":"1622_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/00127893-200209000-00004","volume":"8","author":"FH Rossi","year":"2002","unstructured":"Rossi\u00a0FH, Okun\u00a0M, Yachnis\u00a0A, Quisling\u00a0R, Triggs\u00a0WJ (2002) Corticosteroid treatment of mitochondrial encephalomyopathies. Neurologist 8:313\u2013315. https:\/\/doi.org\/10.1097\/00127893-200209000-00004","journal-title":"Neurologist"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01622-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-024-01622-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01622-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T13:05:04Z","timestamp":1707311104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-024-01622-8"}},"subtitle":["Energiedefizit im Gehirn","Energy deficit in the brain"],"short-title":[],"issued":{"date-parts":[[2024,1,26]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1622"],"URL":"https:\/\/doi.org\/10.1007\/s00115-024-01622-8","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,26]]},"assertion":[{"value":"26 January 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>L.\u00a0H\u00e4mmerl<\/b>: A.\u00a0Finanzielle Interessen: L.\u00a0H\u00e4mmerl gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: angestellte \u00c4rztin in Weiterbildung, Neurologie, Klinikum St. Georg, Leipzig. <b>T.\u00a0Kraya<\/b>: A.\u00a0Finanzielle Interessen: Firma Novartis.\u00a0\u2013 Honorare, Unterkunft und Fahrtkosten: Abbvie, TEVA, Lilly, Hormosan, Novartis.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Chefarzt, Klinik f\u00fcr Neurologie, Klinikum St. Georg, Leipzig, Leiter Zentrum f\u00fcr Innere Medizin, Vizepr\u00e4sident der Deutschen Migr\u00e4ne- und Kopfschmerzgesellschaft.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}